pharmacie et médicaments – Pénurie des spécialités pharmaceutiques Praluent et Repatha

This written question asks about the causes and potential solutions for shortages of the pharmaceutical specialties Praluent and Repatha. It highlights concerns regarding patient access to essential medicines. The question seeks information on measures being taken by the government to address these shortages and ensure a stable supply of these drugs for patients in France.